- Home
- NERV vs AGMH Comparison
NERV vs AGMH Comparison
Compare NERV & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- AGMH
- Stock Information
- Founded
- NERV 2007
- AGMH 2015
- Country
- NERV United States
- AGMH Hong Kong
- Employees
- NERV N/A
- AGMH N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- AGMH EDP Services
- Sector
- NERV Health Care
- AGMH Technology
- Exchange
- NERV Nasdaq
- AGMH Nasdaq
- Market Cap
- NERV 14.6M
- AGMH 17.1M
- IPO Year
- NERV 2014
- AGMH 2018
- Fundamental
- Price
- NERV $4.78
- AGMH $4.42
- Analyst Decision
- NERV Hold
- AGMH
- Analyst Count
- NERV 1
- AGMH 0
- Target Price
- NERV $5.00
- AGMH N/A
- AVG Volume (30 Days)
- NERV 9.3M
- AGMH 134.7K
- Earning Date
- NERV 11-05-2025
- AGMH 11-18-2025
- Dividend Yield
- NERV N/A
- AGMH N/A
- EPS Growth
- NERV N/A
- AGMH N/A
- EPS
- NERV 1.48
- AGMH 16.43
- Revenue
- NERV N/A
- AGMH $48,526,743.00
- Revenue This Year
- NERV N/A
- AGMH N/A
- Revenue Next Year
- NERV N/A
- AGMH N/A
- P/E Ratio
- NERV $3.06
- AGMH $0.21
- Revenue Growth
- NERV N/A
- AGMH 18.80
- 52 Week Low
- NERV $1.15
- AGMH $1.09
- 52 Week High
- NERV $12.46
- AGMH $99.47
- Technical
- Relative Strength Index (RSI)
- NERV 63.84
- AGMH 42.46
- Support Level
- NERV $4.27
- AGMH $4.15
- Resistance Level
- NERV $12.46
- AGMH $4.70
- Average True Range (ATR)
- NERV 0.86
- AGMH 0.45
- MACD
- NERV 0.16
- AGMH -0.22
- Stochastic Oscillator
- NERV 24.84
- AGMH 18.59
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.